KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

RA CAPITAL MANAGEMENT, L.P.'s Holding History (CIK: 0001346824)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 4,264,144 Value ($000) $26,651 Avg Close — Range —
Q4 2022
Shares 4,264,144 Value ($000) $26,011 Avg Close — Range —
Q3 2022
Shares 4,264,144 Value ($000) $50,956 Avg Close — Range —
Q2 2022
Shares 4,264,144 Value ($000) $53,771 Avg Close — Range —
Q1 2022
Shares 4,264,144 Value ($000) $48,014 Avg Close — Range —
Q4 2021
Shares 3,593,052 Value ($000) $63,669 Avg Close — Range —
Q3 2021
Shares 3,593,052 Value ($000) $82,712 Avg Close — Range —
Q2 2021
Shares 3,593,052 Value ($000) $83,646 Avg Close — Range —
Q1 2021
Shares 3,593,052 Value ($000) $111,960 Avg Close — Range —
Q4 2020
Shares 3,593,052 Value ($000) $142,932 Avg Close — Range —